期刊文献+

高龄患者心血管疾病危险因素与超敏C反应蛋白的相关性研究 被引量:2

原文传递
导出
摘要 目的:探讨高龄患者心血管疾病危险因素与超敏C反应蛋白(hs-CRP)的相关性。方法:选择门诊和住院高龄心血管疾病966例,着重分析吸烟、高血压、高血脂、冠心病、家族史等心血管疾病危险因素与hs-CRP的相关性。结果:(1)除低密度脂蛋白胆固醇(LDL-C)增高患者的hs-CRP水平与正常LDL-C患者差异不显著外,具有其他心血管疾病危险因素患者的hs-CRP水平,均显著高于不具有该危险因素患者(P<0.05)。(2)Logistic逐步回归分析结果提示,男性、冠心病、糖尿病和HDL-C异常进入以hs-CRP为因变量的回归方程(P<0.05,P<0.01)。(3)男性与女性分别按照Framingham危险因素个数分组后,随着合并危险因素个数的增加,高hs-CRP的暴露率随之增高。结论:高龄患者心血管疾病危险程度与hs-CRP水平显著相关。
机构地区 解放军第
出处 《人民军医》 2016年第2期161-163,共3页 People's Military Surgeon
  • 相关文献

参考文献7

  • 1Saehdeva A,Cannon CP,Deedwania PC,et al. Lipid levels in patients hospitalized with coronary artery disease:An analysis of 136,905 hos- pitalizations in get with the Guidelines[J]. Am Heart J, 2009,157 (1) : 111-117.
  • 2Momiyama Y, Ohmori R, Fayad ZA,et al. Associations between plas- ma C-reactive protein levels and the severities of coronary and aortic atherosclerosis[J]. J Atheroscler Thromb,2010,17(5) ..460-467.
  • 3Corrado E, Rizzo M,Coppola G,et al. An update on the role of mark- ers of inflammation in atherosclerosis[J] .J Atheroscler Thromb, 2010,17(1) :1-11.
  • 4Iso H, Noda H, Ikeda A, et al. The impact of C-reactive protein on risk of stroke, stroke subtypes and ischemic heart disease in middle- aged Japanese: The Japan Public Health Center-based Study[J].J Atheroscler Thromb,2012,19(8) :756-766.
  • 5李波,罗燕容,晏沐阳.超敏C反应蛋白等预测不稳定型心绞痛不良事件的价值研究[J].人民军医,2013,56(9):1019-1021. 被引量:2
  • 6王爱文,鹿育萨.正常高值血压与高敏C反应蛋白的相关性[J].中国心血管病研究,2008,6(10):741-743. 被引量:8
  • 7Tohidi M, Hadaegh F, Harati H,et al. C-reactive protein in risk pre- diction of cardiovascular outcomes: Tehran Lipid and Glucose Study [J]. Int J Cardiol, 2009,132(3): 369-374.

二级参考文献18

  • 1孙佳艺,赵冬,王薇,刘静,吴桂贤,王文化,李岩,吴兆苏.北京地区2740人的血压水平10年(1992-2002)变化情况[J].高血压杂志,2005,13(2):115-119. 被引量:130
  • 2陈捷,赵秀丽,武峰,崔艳丽,胡大一.我国14省市中老年人肥胖超重流行现状及其与高血压患病率的关系[J].中华医学杂志,2005,85(40):2830-2834. 被引量:166
  • 3[1]Dana E,Brent M,Arch G,et al.Elevation of C-Reactive Protein in People With Prehypertension.J Clin Hypertens,2004,6:562-568.
  • 4[4]Bautista LE,Lopez-Jaramillo P,Vera LM,et al.Is C-reactive protein an independent risk factor for essential hypertension.J Hypertens,2001,19:857.
  • 5[5]Venugopal SK,Devaraj S,Yuhannan I,et al.Demonstration that C2reactive protein decreases eNOs expression and bioactivity in human aortic endothe2 lial cells.Circulation,2002,106:1439-1441.
  • 6[6]Vasan Ramachandran S,Sullivan Lisa M,Ronenn R,et al.Inflammatorymarlers and risk of heart failure in elderly subjectswithout prior myocardial infarction:the Framingham HeartStudy.Circulation,2003,107:1486-1491.
  • 7[7]Yasunari K,Maeda K,Nakamura M,et al.Oxidative stress inLeukocytes is a possible link between blood pressure,blood glucose,and C-reactive protein.Hypertension,2002,39:777-780.
  • 8[8]Verma S,Li SH,Badiwala MV,et al.Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.Circulation,2002,105:1890-1896.
  • 9[9]Hayaishi-Okano R,Yamasaki Y,Katakami N,et al.Elevated Creactiveprotein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes.Diabetes Care,2002,25:1432-1438.
  • 10[10]Temelkova Kurktschie T,Siegert G,Bergmann S,ct al.Subclinical inflammationis strongly related to insulinresistance but not to impairedinsulin secretion in a high risk populationfor diabetes.Metabolism,2002,51:743-749.

共引文献8

同被引文献27

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部